Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gehrig

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
Gynecologic Oncology|August 29, 2009
An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)Amanda Nickles Fader, David Starks, Paola A Gehrig, et al.
Chemical Communications (Cambridge, England)|January 24, 2015
Enzymatic cleavage of uracil-containing single-stranded DNA linkers for the efficient release of affinity-selected circulating tumor cellsSoumya V Nair, Małgorzata A Witek, Joshua M Jackson, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2013
Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacologyWhitney P Caron, John C Lay, Alan M Fong, et al.
Practical Radiation Oncology|October 24, 2022
Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice GuidelineMatthew M Harkenrider, Nadeem Abu-Rustum, Kevin Albuquerque, et al.
Cancer Chemotherapy and Pharmacology|January 30, 2016
Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancerHugh Giovinazzo, Parag Kumar, Arif Sheikh, et al.
Gynecologic Oncology|January 3, 2009
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomesAmanda Nickles Fader, Christa Nagel, Allison E Axtell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2020
Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review StudyShitanshu Uppal, Paola A Gehrig, Katherine Peng, et al.
Gynecologic Oncology|September 5, 2020
Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?M H Vetter, S Smrz, P A Gehrig, et al.
NPJ Precision Oncology|April 17, 2018
Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion moleculeMałgorzata A Witek, Rachel D Aufforth, Hong Wang, et al.
Gynecologic Oncology|March 8, 2025
A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG studyVictoria L Bae-Jump, Michael W Sill, Paola A Gehrig, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Gynecologic Oncology|August 29, 2009
An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)Amanda Nickles Fader, David Starks, Paola A Gehrig, et al.
Chemical Communications (Cambridge, England)|January 24, 2015
Enzymatic cleavage of uracil-containing single-stranded DNA linkers for the efficient release of affinity-selected circulating tumor cellsSoumya V Nair, Małgorzata A Witek, Joshua M Jackson, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2013
Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacologyWhitney P Caron, John C Lay, Alan M Fong, et al.
Practical Radiation Oncology|October 24, 2022
Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice GuidelineMatthew M Harkenrider, Nadeem Abu-Rustum, Kevin Albuquerque, et al.
Cancer Chemotherapy and Pharmacology|January 30, 2016
Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancerHugh Giovinazzo, Parag Kumar, Arif Sheikh, et al.
Gynecologic Oncology|January 3, 2009
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomesAmanda Nickles Fader, Christa Nagel, Allison E Axtell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2020
Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review StudyShitanshu Uppal, Paola A Gehrig, Katherine Peng, et al.
Gynecologic Oncology|September 5, 2020
Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?M H Vetter, S Smrz, P A Gehrig, et al.
NPJ Precision Oncology|April 17, 2018
Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion moleculeMałgorzata A Witek, Rachel D Aufforth, Hong Wang, et al.
Gynecologic Oncology|March 8, 2025
A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG studyVictoria L Bae-Jump, Michael W Sill, Paola A Gehrig, et al.
Pageof 20